The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Phase 1, first-in-human trial of JTX-8064, an anti-LILRB2/ILT4 monoclonal antibody, as monotherapy and in combination with anti-PD-1 in adult patients with advanced solid tumors (INNATE).
 
Kyriakos P. Papadopoulos
Consulting or Advisory Role - Basilea; Turning Point Therapeutics
Research Funding - 3D Medicines (Inst); Abbvie (Inst); ADC Therapeutics (Inst); Amgen (Inst); Anheart Therapeutics (Inst); Bayer (Inst); Calithera Biosciences (Inst); Daiichi Sankyo (Inst); EMD Serono (Inst); F-star (Inst); Incyte (Inst); Jounce Therapeutics (Inst); Lilly (Inst); Linnaeus Therapeutics (Inst); MabSpace Biosciences (Inst); MedImmune (Inst); Merck (Inst); Mersana (Inst); Mirati Therapeutics (Inst); Peloton Therapeutics (Inst); Pfizer (Inst); Regeneron (Inst); Syros Pharmaceuticals (Inst); Tempest Therapeutics (Inst); Treadwell Therapeutics (Inst)
 
Nehal J. Lakhani
Consulting or Advisory Role - Innovent Biologics
Research Funding - Alexion Pharmaceuticals (Inst); Alexo Therapeutics (Inst); Alpine Immune Sciences (Inst); Alpine Immune Sciences (Inst); Apexian Pharmaceuticals (Inst); Asana Biosciences (Inst); Ascentage Pharma (Inst); Astellas Pharma (Inst); BeiGene (Inst); Celgene (Inst); Celgene (Inst); Cerulean Pharma (Inst); Constellation Pharmaceuticals (Inst); Coordination Therapeutics (Inst); CytomX Therapeutics (Inst); Epizyme (Inst); Formation Biologics (Inst); Forty Seven (Inst); Genmab (Inst); Genmab (Inst); Helsinn Therapeutics (Inst); Ikena Oncology (Inst); Ikena Oncology (Inst); Incyte (Inst); InhibRx (Inst); Innovent Biologics; Innovent Biologics (Inst); Jounce Therapeutics (Inst); LAM Therapeutics (Inst); Lilly (Inst); Livzon (Inst); Loxo (Inst); Macrogenics (Inst); Merck (Inst); Mersana (Inst); Northern Biologics (Inst); Odonate Therapeutics (Inst); Pfizer (Inst); Regeneron (Inst); Sapience Therapeutics (Inst); Seagen (Inst); Shattuck Labs (Inst); Symphogen (Inst); TaiRx, Inc. (Inst); Tesaro (Inst)
 
Timothy A. Yap
Consulting or Advisory Role - Aduro Biotech; Almac Diagnostics; AstraZeneca; Atrin Pharmaceuticals; Axiom Biotechnologies; Bayer; Bristol-Myers Squibb; Calithera Biosciences; Clovis Oncology; Cybrexa Therapeutics; EMD Serono; F-Star; Guidepoint Global; I-Mab; Ignyta; Janssen; Merck; Pfizer; Repare Therapeutics; Roche; Rubius Therapeutics; Schrodinger; Seagen; Varian Medical Systems; Zai Lab
Research Funding - Artios (Inst); AstraZeneca (Inst); Bayer (Inst); Clovis Oncology (Inst); Constellation Pharmaceuticals (Inst); Cyteir (Inst); EMD Serono (Inst); F-Star (Inst); Forbius (Inst); Genentech (Inst); GlaxoSmithKline (Inst); ImmuneSensor Therapeutics (Inst); Ipsen (Inst); Jounce Therapeutics (Inst); Karyopharm Therapeutics (Inst); Kyowa Hakko Kirin (Inst); Lilly (Inst); Merck (Inst); Novartis (Inst); Pfizer (Inst); Regeneron (Inst); Repare Therapeutics (Inst); Ribon Therapeutics (Inst); Sanofi (Inst); Scholar Rock (Inst); Seagen (Inst); Tesaro (Inst); Vertex (Inst)
 
Allison L Naumovski
Employment - AstraZeneca; Jounce Therapeutics
Stock and Other Ownership Interests - AstraZeneca; Jounce Therapeutics
 
Karen S Brown
Employment - Certara Inc; Jounce Therapeutics; PTC Therapeutics
Stock and Other Ownership Interests - PTC Therapeutics
 
Ben Umiker
Employment - Jounce Therapeutics
Stock and Other Ownership Interests - Jounce Therapeutics
Patents, Royalties, Other Intellectual Property - Evelo Biosciences (I)
 
Lara McGrath
Employment - Jounce Therapeutics
Stock and Other Ownership Interests - Jounce Therapeutics
Research Funding - Jounce Therapeutics
Patents, Royalties, Other Intellectual Property - Jounce Therapeutics
 
Weidong Zhang
Employment - Jounce Therapeutics
Stock and Other Ownership Interests - Jounce Therapeutics; Pfizer
Patents, Royalties, Other Intellectual Property - Pfizer
Travel, Accommodations, Expenses - Pfizer
 
Edward Stack
Employment - Jounce Therapeutics
Stock and Other Ownership Interests - Jounce Therapeutics
 
Gosia Riley
No Relationships to Disclose
 
Nancy Mota
No Relationships to Disclose
 
Christina Tasillo
No Relationships to Disclose
 
Haley Laken
Employment - Jounce Therapeutics
Stock and Other Ownership Interests - Jounce Therapeutics
Travel, Accommodations, Expenses - Jounce Therapeutics
 
Elizabeth G. Trehu
Employment - Jounce Therapeutics
Leadership - Constellation Pharmaceuticals; Jounce Therapeutics
Stock and Other Ownership Interests - Jounce Therapeutics
Patents, Royalties, Other Intellectual Property - I am an inventor on a patent for PRM-151 for treatment of fibrotic diseases.; I am an inventor on a patent for PRM-151 for treatment of fibrotic diseases.
Travel, Accommodations, Expenses - Jounce Therapeutics
 
Johan Baeck
Employment - Jounce Therapeutics
Stock and Other Ownership Interests - Jounce Therapeutics